Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
type: MedicalStudy
description: Phase I/II Study of Stereotactic Radiation and Sacituzumab Govitecan With Zimberelimab in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases (TARGET-TNBC)
status: RECRUITING
study design: INTERVENTIONAL
phase: PHASE1,PHASE2
start date: 2024-12-19
end date: 2027-02
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT06238921
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: H. Lee Moffitt Cancer Center and Research Institute
study subject: Breast Cancer
study subject: Triple Negative Breast Cancer
keywords: PHASE1,PHASE2
keywords: INTERVENTIONAL
keywords: RECRUITING
keywords: Breast Cancer
keywords: Triple Negative Breast Cancer

AI Analytics
type: Organization